Targeting GPCR-Gαq Signaling Overcomes Trametinib Resistance in BRAF-Mutant Melanoma
A cross-species study reveals that GPCR-Gαq-PLC-PKC signaling drives adaptive resistance to trametinib in BRAF-mutant melanoma, highlighting a potential combination therapy ...

